Serum omentin-1 levels in type II diabetes and its relationship with obesity

Y. Abdullatif, Karima Y. Ahmed, Fatma M. El-Senosy, Rasha Mohammed Abd El-Aziz
{"title":"Serum omentin-1 levels in type II diabetes and its relationship with obesity","authors":"Y. Abdullatif, Karima Y. Ahmed, Fatma M. El-Senosy, Rasha Mohammed Abd El-Aziz","doi":"10.4103/sjamf.sjamf_227_21","DOIUrl":null,"url":null,"abstract":"Background Diabetes mellitus (DM) is a complex metabolic disorder, and its rapid emergence worldwide has led to its classification as an epidemic. Aim To increase our knowledge about omentin-1 and its relation with type 2 DM, insulin resistance, and obesity. Patients and methods This study included 50 patients with type 2 DM, with an age range from 40 to 70 years, who were divided into two groups (25 obese and 25 nonobese), as well as 40 age group (20 obese and 20 nonobese)-matched patients, who formed the control group. Each group was subjected to full history taking and clinical examination (fasting blood glucose, total cholesterol, triglycerides, low-density lipoprotein-cholesterol, glycosylated hemoglobin, fasting insulin, and serum omentin-1 levels). Weight and height were measured. Homeostasis model assessment insulin resistance and BMI were calculated. Results The study showed a significant decrease in serum omentin-1 levels in type 2 diabetic patients in comparison with the control group. Serum omentin-1 levels inversely correlated with obesity, insulin resistance, and systolic blood pressure. Negative associations were found between serum omentin-1 level and fasting glucose, glycosylated hemoglobin, and fasting lipid levels. Conclusion Omentin-1 may be used as a biomarker for obesity and associated metabolic and vascular disorders.","PeriodicalId":22975,"journal":{"name":"The Scientific Journal of Al-Azhar Medical Faculty, Girls","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Scientific Journal of Al-Azhar Medical Faculty, Girls","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/sjamf.sjamf_227_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background Diabetes mellitus (DM) is a complex metabolic disorder, and its rapid emergence worldwide has led to its classification as an epidemic. Aim To increase our knowledge about omentin-1 and its relation with type 2 DM, insulin resistance, and obesity. Patients and methods This study included 50 patients with type 2 DM, with an age range from 40 to 70 years, who were divided into two groups (25 obese and 25 nonobese), as well as 40 age group (20 obese and 20 nonobese)-matched patients, who formed the control group. Each group was subjected to full history taking and clinical examination (fasting blood glucose, total cholesterol, triglycerides, low-density lipoprotein-cholesterol, glycosylated hemoglobin, fasting insulin, and serum omentin-1 levels). Weight and height were measured. Homeostasis model assessment insulin resistance and BMI were calculated. Results The study showed a significant decrease in serum omentin-1 levels in type 2 diabetic patients in comparison with the control group. Serum omentin-1 levels inversely correlated with obesity, insulin resistance, and systolic blood pressure. Negative associations were found between serum omentin-1 level and fasting glucose, glycosylated hemoglobin, and fasting lipid levels. Conclusion Omentin-1 may be used as a biomarker for obesity and associated metabolic and vascular disorders.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2型糖尿病患者血清网膜蛋白-1水平及其与肥胖的关系
糖尿病(DM)是一种复杂的代谢性疾病,在世界范围内迅速出现,已被列为流行病。目的提高人们对网膜蛋白-1及其与2型糖尿病、胰岛素抵抗和肥胖之间关系的认识。患者与方法本研究纳入50例年龄在40 ~ 70岁的2型糖尿病患者,分为两组(肥胖组25例,非肥胖组25例)和40组(肥胖组20例,非肥胖组20例)相匹配的患者作为对照组。各组均进行全部病史和临床检查(空腹血糖、总胆固醇、甘油三酯、低密度脂蛋白-胆固醇、糖化血红蛋白、空腹胰岛素、血清网膜蛋白-1水平)。测量了体重和身高。计算体内平衡模型评估胰岛素抵抗和BMI。结果与对照组相比,2型糖尿病患者血清网膜蛋白-1水平明显降低。血清网膜蛋白-1水平与肥胖、胰岛素抵抗和收缩压呈负相关。血清omentin-1水平与空腹血糖、糖化血红蛋白和空腹血脂水平呈负相关。结论Omentin-1可作为肥胖及相关代谢和血管疾病的生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Evaluation of nanofat injection in postburn and post-traumatic facial scars Immunological markers changes in pediatric immune Thrombocytopenic Purpura Minimally invasive strabismus surgery versus paralimbal approach for horizontal strabismus surgery Clinical applications of brain diffusion-tensor imaging and fiber tractography Choroidal and retinal nerve fiber layer thicknesses in smokers
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1